Palonosetron Hydrochloride Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2025-11-14 · last update 2025-11-14
Manufacturers: Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Palonosetron Hydrochloride, Injection, .25 mg/5 mL (NDC 0703-4094-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 11/14/2025 Updated 11/14/2025 Discontinued 11/14/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)